New York Times
There Is No Single, Best Policy for Drug Prices
Opinion by Austin Frakt, associate professor of health law, policy & management
Futurity
‘Behind the Counter’ Meds Could Safely Treat Opioid Addiction
Interview with Michael Stein, professor and chair of health law, policy & management
Addiction Professional
Viewpoint: It’s Time to Get Buprenorphine Behind the Pharmacy Counter
Quotes Michael Stein, professor and chair of health law, policy & management
Medical Xpress
Allowing the Sale of Buprenorphine without a Prescription Could Save Lives
Quotes Michael Stein, professor and chair of health law, policy & management
Science 2.0
Buprenorphine Is a Schedule III Drug for Opioid Addiction — Taking It off Prescription Will Save Lives
Quotes Michael Stein, professor and chair of health law, policy & management
Globe Post
Facing Opposition from Drug Companies, Trump Weighs Plan to Match Prices to World Average
Quotes Alan Sager, professor of health law, policy & management
Bloomberg Law
Trump Pens Health-Care Order, Now Agencies Must Make It Happen
Quotes Wendy Mariner, Edward R. Utley Professor of health law, bioethics & human rights
The Hill
‘Big Pharma’ Is the Big Winner of the USMCA
Opinion co-authored by Veronika Wirtz, associate professor of global health, and Warren Kaplan, clinical assistant professor of global health
Scientific American
Humility Is the First Step toward a Healthier World
Opinion by Dean Sandro Galea
Boston Herald
Express Scripts’ $25 Monthly Cap on Insulin a ‘Smoke Screen’
Quotes Alan Sager, professor of health law, policy & management